• Investing Ideas
  • /
  • Hong Kong Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
6 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

719

Shandong Xinhua Pharmaceutical
HK$5.29-4.7%-14.4%HK$9.8bn/aPE6.5xn/a4.1%

1061

Essex Bio-Technology
HK$2.360%-39.3%HK$1.3bHK$5.12PE4.9xE28.7%3.8%

2633

Jacobson Pharma
HK$0.58-3.3%-37.6%HK$1.2bn/aPE4.7xn/a8.4%

8049

Jilin Province Huinan Changlong Bio-pharmacy
HK$1.75-5.4%52.2%HK$980.4mn/aPE4.1xn/a30.9%

503

Lansen Pharmaceutical Holdings
HK$1.790%23.6%HK$750.6mn/aPE13xn/a2.7%

8329

Shenzhen Neptunus Interlong Bio-technique
HK$0.160.6%-10.1%HK$270.2mn/aPE3.9xn/an/a
Page 1 of 1
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.